Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
RX
- Prescription Medicines
DOXAZOSIN ARENA 1 mg
Adrenergic alpha-blocker indicated in arterial hypertension and benign prostatic hyperplasia
Tablets
1 mg
EFEDRINA ARENA 50 mg
Sympathomimetic drug with nasal decongestant and bronchodilator effect
Tablets
50 mg
ENALAPRIL ARENA 10 mg
Angiotensin-converting enzyme inhibitor, indicated in arterial hypertension and heart failure
Tablets
10 mg
ENALAPRIL ARENA 20 mg
Angiotensin-converting enzyme inhibitor, indicated in arterial hypertension and heart failure
Tablets
20 mg
ENALAPRIL ARENA 5,mg
Angiotensin-converting enzyme inhibitor, indicated in arterial hypertension and heart failure
Tablets
5,mg
EPLERENONA ARENA 25 mg
Selective aldosterone receptor antagonist, indicated in heart failure
Film-coated tablets
25 mg
EPLERENONA ARENA 50 mg
Selective aldosterone receptor antagonist, indicated in heart failure
Film-coated tablets
50 mg
ETAMBUTOL ARENA 250 mg
Antituberculosis drug, used in combination for the treatment of tuberculosis
Capsules
250 mg
ETAMBUTOL ARENA 400 mg
Antituberculosis drug, used in combination for the treatment of tuberculosis
Capsules
400 mg